Skip to main content
Fig. 2 | BMC Cardiovascular Disorders

Fig. 2

From: Serum amyloid a protein as a potential biomarker in predicting acute onset and association with in-hospital death in acute aortic dissection

Fig. 2

Analysis of SAA levels in different groups. a Comparison of SAA levels among controls, TAAD and TBAD. And sub-group analysis of SAA levels in AAD patients: b comparison of SAA levels between AAD with high-risk pain features that persisted less than six hours and more than six hours, and c comparison of SAA levels between AAD with communicating and non-communicating false lumen (C and NC), and d comparison of SAA levels between death cases and survival cases. *P < 0.05, **P < 0.01, ***P < 0.001, ns, no significance

Back to article page